Navigation Links
Vaginal Mesh Lawsuits Pick Up Momentum, According To Pulaski & Middleman, LLC
Date:8/1/2012

HOUSTON, Aug. 1, 2012 /PRNewswire/ -- Last week, a jury awarded Christine Scott of Bakersfield, CA, and her husband, $5.5 million for pain and suffering, medical expenses and economic loss, in a case against C.R. Bard.  Ms. Scott had the Bard Avaulta Mesh implant surgery to correct a leaky bladder.  After a four year legal battle, Scott's case is the first in the nation against the maker of a pelvic mesh implant who claimed Avaulta knew their product was unsafe.

There are thousands of vaginal or pelvic mesh lawsuits against several manufacturers across the country. Filings with the Securities and Exchange Commission indicate 47,000 women have had the Avaulta Mesh implanted and 650 lawsuits are pending. Johnson & Johnson, maker of the Gynecare Prolift device, faces more than 1,400 lawsuits who claim the mesh causes significant pain, scarring, nerve damage and organ perforation.

In the Scott case, the mesh began cutting into her colon and tissue continued to grow through the tiny holes in the mesh. Since the surgery, Ms. Scott has had eight corrective surgeries.

Common side effects of vaginal mesh medical devices include pain during intercourse or urination, chronic pain, infection, urinary problems, bleeding, mesh migration, bladder and blood vessel perforation and additional corrective surgeries for repair or removal. Vaginal mesh attorneys are urging women who have been adversely affected by vaginal mesh implants to contact an experienced medical device lawyer.

The lawyers at Pulaski & Middleman, LLC, are committed to holding pharmaceutical and medical device companies accountable for their dangerous products.  Pulaski & Middleman, LLC, represents more than 9,000 women from across the United States who experienced serious painful side effects after having vaginal mesh implant surgery.

Contact the professional vaginal mesh attorneys at Pulaski & Middleman, LLC today if you or a loved one has been affected by the adverse side effects of defective medical devices, contact us toll free at 1-800-BAD-DRUG.


'/>"/>
SOURCE Pulaski & Middleman, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
2. N.J. Woman Sues Johnson & Johnsons Ethicon Unit Over Vaginal Mesh Injuries, Says The Lanier Law Firm
3. DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter
4. Filing Yaz Class Action Lawsuits Before They Expire
5. Shingles Vaccine is Safe, According to New Study
6. Vaccines are dangerous, according to Saynotovaccines.org - Get all the facts!
7. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
8. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
9. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
10. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
11. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Inc. (NASDAQ: IONS ), the leader in antisense therapeutics, ... BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December ... A live webcast of the presentation will be available on the ... be available within 48 hours and will be archived for a ... , , ...
(Date:12/7/2016)... PHILADELPHIA , Dec. 7, 2016  Lannett Company, Inc. (NYSE: ... at the BMO Capital Markets 2016 Prescription for Success Healthcare Conference ... Barclay hotel in New York City . ... investors participating at the Guggenheim Securities 4 th Annual Boston ... Boston hotel. ...
(Date:12/6/2016)... 2016  Alopexx Oncology, LLC announced data from a ... protein (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal ... B cells as Rituxan and maintains the activities of ... involved in tumor targeting, engagement of the immune system, ... of the study (abstract #95954) were presented at the ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 2016 BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s ... achieved through user experience. , BOC Global Events & Training Group is a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, LA.c., a certified ... Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility ... patients realize their family building goals. Acupuncture helps fertility patients by ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief ... the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of ... can for this country. , Nancy attributes her patriotic nature to her WWII veteran ...
(Date:12/7/2016)... ... ... “Fred Rides a Train” allows readers to tag along on a special ... Train” is the creation of published author, Janet Morrison, who has been writing mostly ... "Fred, the Dog" series is her first attempt at writing for children. Janet, Fred, ...
Breaking Medicine News(10 mins):